User profiles for Martin Skarzynski

Martin Skarzynski

National Cancer Institute
Verified email at mail.nih.gov
Cited by 463

Using prediction models to reduce persistent racial and ethnic disparities in the draft 2020 USPSTF lung cancer screening guidelines

R Landy, CD Young, M Skarzynski… - JNCI: Journal of the …, 2021 - academic.oup.com
We examined whether draft 2020 United States Preventive Services Task Force (USPSTF)
lung cancer screening recommendations “partially ameliorate racial disparities in screening …

Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma

…, D Behrend, MA Weniger, M Skarzynski… - Blood, The Journal …, 2016 - ashpublications.org
To interrogate signaling pathways activated in mantle cell lymphoma (MCL) in vivo, we
contrasted gene expression profiles of 55 tumor samples isolated from blood and lymph nodes …

Interactions between ibrutinib and anti-CD20 antibodies: competing effects on the outcome of combination therapy

M Skarzynski, CU Niemann, YS Lee, S Martyr… - Clinical Cancer …, 2016 - AACR
Purpose: Clinical trials of ibrutinib combined with anti-CD20 monoclonal antibodies (mAb)
for chronic lymphocytic leukemia (CLL) report encouraging results. Paradoxically, in …

Variants in SARS-CoV-2 associated with mild or severe outcome

JD Voss, M Skarzynski, EM McAuley… - … medicine, and public …, 2021 - academic.oup.com
Introduction The coronavirus disease 2019 (COVID-19) pandemic is a global public health
emergency causing a disparate burden of death and disability around the world. The viral …

Designing the Furin-Cleavable Linker in Recombinant Immunotoxins Based on Pseudomonas Exotoxin A

JE Weldon, M Skarzynski, JA Therres… - Bioconjugate …, 2015 - ACS Publications
Recombinant immunotoxins (RITs) are fusion proteins that join antibodies to protein toxins
for targeted cell killing. RITs armed with Pseudomonas exotoxin A (PE) are undergoing …

Harnessing the fcμ receptor for potent and selective cytotoxic therapy of chronic lymphocytic leukemia

B Vire, M Skarzynski, JD Thomas, CG Nelson, A David… - Cancer research, 2014 - AACR
Chronic lymphocytic leukemia (CLL) is a B-cell malignancy in need of new, effective, and
safe therapies. The recently identified IgM receptor FcμR is overexpressed on malignant B …

[HTML][HTML] Health disparities in the immunoprevention of human papillomavirus infection and associated malignancies

AH Bakir, M Skarzynski - Frontiers in Public Health, 2015 - frontiersin.org
Human papillomavirus (HPV) causes roughly 1.6% of the plus 1.6 million cases of cancer
that are diagnosed in the United States each year. Despite the proven safety and efficacy of …

SARS-CoV-2 genome-based severity predictions correspond to lower qPCR values and higher viral load

M Skarzynski, EM McAuley, EJ Maier… - Global Health …, 2022 - cambridge.org
The 2019 coronavirus disease (COVID-19) pandemic has demonstrated the importance of
predicting, identifying, and tracking mutations throughout a pandemic event. As the COVID-19 …

SOLOMON: An ontology for sensory-onset, language-onset and motor-onset dementias

M Skarzynski, A Craig, C Taswell - 2015 IEEE International …, 2015 - ieeexplore.ieee.org
The PORTAL-DOORS system (PDS) has been designed as a resource metadata management
system intended to support applications such as automated searches of online resources …

Recalibration of a deep learning model for low-dose computed tomographic images to inform lung cancer screening intervals

…, LC Cheung, PE Castle, M Skarzynski… - JAMA Network …, 2023 - jamanetwork.com
Importance Annual low-dose computed tomographic (LDCT) screening reduces lung cancer
mortality, but harms could be reduced and cost-effectiveness improved by reusing the …